annual cash & cash equivalents:
$142.71M-$5.93M(-3.99%)Summary
- As of today (July 1, 2025), XENE annual cash & cash equivalents is $142.71 million, with the most recent change of -$5.93 million (-3.99%) on December 31, 2024.
- During the last 3 years, XENE annual cash & cash equivalents has fallen by -$32.98 million (-18.77%).
- XENE annual cash & cash equivalents is now -18.77% below its all-time high of $175.69 million, reached on December 31, 2021.
Performance
XENE Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$116.66M-$26.05M(-18.26%)Summary
- As of today (July 1, 2025), XENE quarterly cash & cash equivalents is $116.66 million, with the most recent change of -$26.05 million (-18.26%) on March 31, 2025.
- Over the past year, XENE quarterly cash & cash equivalents has increased by +$57.76 million (+98.07%).
- XENE quarterly cash & cash equivalents is now -68.47% below its all-time high of $369.99 million, reached on June 30, 2022.
Performance
XENE quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
XENE Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -4.0% | +98.1% |
| 3 y3 years | -18.8% | +0.1% |
| 5 y5 years | +476.5% | +92.8% |
XENE Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -18.8% | +149.3% | -68.5% | +103.8% |
| 5 y | 5-year | -18.8% | +476.5% | -68.5% | +672.6% |
| alltime | all time | -18.8% | +734.8% | -68.5% | +694.2% |
XENE Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $116.66M(-18.3%) |
| Dec 2024 | $142.71M(-4.0%) | $142.71M(+62.9%) |
| Sep 2024 | - | $87.62M(-35.9%) |
| Jun 2024 | - | $136.73M(+132.2%) |
| Mar 2024 | - | $58.90M(-60.4%) |
| Dec 2023 | $148.64M(+159.7%) | $148.64M(+49.3%) |
| Sep 2023 | - | $99.57M(+54.3%) |
| Jun 2023 | - | $64.55M(-7.1%) |
| Mar 2023 | - | $69.51M(+21.4%) |
| Dec 2022 | $57.24M(-67.4%) | $57.24M(-44.7%) |
| Sep 2022 | - | $103.49M(-72.0%) |
| Jun 2022 | - | $369.99M(+217.5%) |
| Mar 2022 | - | $116.54M(-33.7%) |
| Dec 2021 | $175.69M(+290.3%) | $175.69M(+100.1%) |
| Sep 2021 | - | $87.81M(+5.9%) |
| Jun 2021 | - | $82.93M(-5.7%) |
| Mar 2021 | - | $87.98M(+95.5%) |
| Dec 2020 | $45.01M(+81.8%) | $45.01M(+198.1%) |
| Sep 2020 | - | $15.10M(-65.8%) |
| Jun 2020 | - | $44.20M(-27.0%) |
| Mar 2020 | - | $60.51M(+144.4%) |
| Dec 2019 | $24.75M | $24.75M(-34.3%) |
| Sep 2019 | - | $37.67M(+1.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $37.08M(-28.9%) |
| Mar 2019 | - | $52.18M(-23.0%) |
| Dec 2018 | $67.75M(+230.7%) | $67.75M(-23.0%) |
| Sep 2018 | - | $87.96M(+85.4%) |
| Jun 2018 | - | $47.44M(+175.8%) |
| Mar 2018 | - | $17.20M(-16.0%) |
| Dec 2017 | $20.49M(+19.8%) | $20.49M(+39.5%) |
| Sep 2017 | - | $14.69M(-36.4%) |
| Jun 2017 | - | $23.09M(+14.5%) |
| Mar 2017 | - | $20.16M(+17.9%) |
| Dec 2016 | $17.09M(-70.9%) | $17.09M(-68.4%) |
| Sep 2016 | - | $54.13M(+53.7%) |
| Jun 2016 | - | $35.21M(-37.2%) |
| Mar 2016 | - | $56.06M(-4.4%) |
| Dec 2015 | $58.65M(-18.6%) | $58.65M(-10.4%) |
| Sep 2015 | - | $65.47M(+1.7%) |
| Jun 2015 | - | $64.35M(-2.4%) |
| Mar 2015 | - | $65.92M(-8.5%) |
| Dec 2014 | $72.03M(+89.8%) | $72.03M(+113.5%) |
| Sep 2014 | - | $33.73M(-3.9%) |
| Jun 2014 | - | $35.09M(-7.5%) |
| Dec 2013 | $37.95M(-36.9%) | $37.95M |
| Dec 2012 | $60.16M | - |
FAQ
- What is Xenon Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is Xenon Pharmaceuticals quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals quarterly cash & cash equivalents year-on-year change?
What is Xenon Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of XENE is $142.71M
What is the all time high annual cash & cash equivalents for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high annual cash & cash equivalents is $175.69M
What is Xenon Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, XENE annual cash & cash equivalents has changed by -$5.93M (-3.99%)
What is Xenon Pharmaceuticals quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of XENE is $116.66M
What is the all time high quarterly cash & cash equivalents for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high quarterly cash & cash equivalents is $369.99M
What is Xenon Pharmaceuticals quarterly cash & cash equivalents year-on-year change?
Over the past year, XENE quarterly cash & cash equivalents has changed by +$57.76M (+98.07%)